N Verses Capital, LLC Veracyte, Inc. Transaction History
N Verses Capital, LLC
- $219 Billion
- Q3 2024
A detailed history of N Verses Capital, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 6,500 shares of VCYT stock, worth $242,710. This represents 0.1% of its overall portfolio holdings.
Number of Shares
6,500
Previous 3,900
66.67%
Holding current value
$242,710
Previous $84.5 Million
161.81%
% of portfolio
0.1%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
270Shares Held
78.7MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$291 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$280 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$257 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$184 Million1.59% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT3.17MShares$118 Million0.44% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.67B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...